WallStreetZenWallStreetZen

NASDAQ: BCRX
Biocryst Pharmaceuticals Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Biocryst Pharmaceuticals earnings were -$458.0M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest BCRX earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$721.8M, down 393.6% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, BCRX reported annual earnings of $263.9M, with -396.9% growth. The next BCRX earnings date is Aug 3, 2026.

BCRX earnings history

Current Revenue
$885.7M
Current Earnings
-$458.0M
Current Profit Margin
-51.7%

BCRX Return on Equity

Insufficient data to display

BCRX Return on Assets

Current Company
-97.3%
Current Industry
-13.7%
BCRX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when BCRX announces earnings.

BCRX Return on Capital Employed

Current Company
-140.55%
Current Industry
-9.5%
BCRX's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

BCRX vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
BCRX-$377.50M-$457.98MN/A-$1.73
VERA-$359.76M-$368.95MN/A-$5.54
KOD-$204.73M-$230.66MN/A-$4.17
RARE-$571.22M-$608.92MN/A-$6.10
NTLA-$378.97M-$394.60MN/A-$3.53
View Top Biotech Stocks

BCRX earnings dates

Next earnings date
Aug 3, 2026

Biocryst Pharmaceuticals Earnings Reports & History FAQ

What were Biocryst Pharmaceuticals's earnings last quarter?

Biocryst Pharmaceuticals (NASDAQ: BCRX) reported Q1 2026 earnings per share (EPS) of -$2.98, up Infinity% year over year. Total BCRX earnings for the quarter were -$721.81 million. In the same quarter last year, Biocryst Pharmaceuticals's earnings per share (EPS) was $0.00.

If you're new to stock investing, here's how to buy Biocryst Pharmaceuticals stock.

When does Biocryst Pharmaceuticals report earnings?

The next BCRX earnings date is Invalid Date. Add BCRX to your watchlist to be reminded of Biocryst Pharmaceuticals's next earnings date.

Is Biocryst Pharmaceuticals profitable or losing money?

As of the last Biocryst Pharmaceuticals earnings report, Biocryst Pharmaceuticals is currently losing money. Biocryst Pharmaceuticals's net profit (also called net income) for the twelve months ending Mar 31, 2026 was -$457.98 million, a 756.52% increase year over year.

What was BCRX's earnings growth in the past year?

As of Biocryst Pharmaceuticals's earnings date in Q2 2026, Biocryst Pharmaceuticals's earnings has grown year over year. BCRX earnings in the past year totalled -$457.98 million.

What are Biocryst Pharmaceuticals's earnings expectations?

The current EPS estimate for Biocryst Pharmaceuticals's earnings report in Invalid Date is $0.25.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.